升柏控股(02340.HK)2021年淨利1961.2萬港元 同比增加37.99%
格隆匯3月29日丨升柏控股(02340.HK)公佈,截至2021年12月31日止年度,公司收益4.3億港元,同比增加11.68%;公司擁有人應占溢利1961.2萬港元,同比增加37.99%;每股盈利3.6港仙。
於報吿年度,集團的業務由室內裝飾及特殊項目業務及中國物業及設施管理業務構成持續經營業務,以及已於2022年1月10日出售予第三方的香港物業及設施管理業務及輔助業務並於報吿年度的財務報表分類為已終止業務所組成。
於報吿年度完成的項目的重大貢獻主要來自4個主要項目,包括兩所國際學校分別位於何文田的附件工程及沙田的改良工程、九龍塘的廟宇重建及銅鑼灣商業中心的加建及改建工程。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.